ResMed slides despite record Q2 sales and profits

January 31, 2013 by MassDevice staff

Shares of medical device company ResMed fall nearly 7% despite record sales and profits for its fiscal 2nd quarter.

ResMed

ResMed (NYSE:RMD) shares fell nearly 7% this morning after the medical device company posted record sales and profits for its fiscal 2nd quarter, but missed Wall Street's earnings expectations.

The San Diego-based medical device company posted profits of $77.9 million, or 53¢ per share, on sales of $376.5 million for the 3 months ended Dec. 31, 2012.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp